Association Between the CYP2C9 Genotype and Hypoglycemia Among Patients With Type 2 Diabetes Receiving Sulfonylurea Treatment: A Meta-analysis
- 주제(키워드) CYP2C9 , hypoglycemia , polymorphism , sulfonylurea , type 2 diabetes
- 주제(기타) Pharmacology & Pharmacy
- 설명문(일반) [Yee, Jeong; Heo, Yunhee; Kim, Hamin; Yoon, Ha Young; Song, Gonjin; Gwak, Hye Sun] Ewha Womans Univ, Coll Pharm, 52 Ewhayeodae, Seoul 03760, South Korea; [Yee, Jeong; Heo, Yunhee; Kim, Hamin; Yoon, Ha Young; Song, Gonjin; Gwak, Hye Sun] Ewha Womans Univ, Grad Sch Pharmaceut Sci, 52 Ewhayeodae gil, Seoul 03760, South Korea
- 등재 SCIE, SCOPUS
- 발행기관 ELSEVIER
- 발행년도 2021
- 총서유형 Journal
- URI http://www.dcollection.net/handler/ewha/000000183448
- 본문언어 영어
- Published As http://dx.doi.org/10.1016/j.clinthera.2021.03.008
초록/요약
Purpose: Two common variants, CYP2C9*2 (Arg144Cys, rs1799853) and CYP2C9*3 (Ile359Leu, rs1057910), are known to reduce the catalytic function of the CYP2C9 enzyme. Because impaired catalytic function is likely to affect sulfonylurea metabolism, it is predictable that CYP2C9 loss-of-function alleles may increase the risk of sulfonylurea-induced hypoglycemia. This systematic review and meta-analysis aimed to assess the association between CYP2C9 genotype and hypoglycemia among patients with type 2 diabetes mellitus (T2DM) receiving sulfonylurea. Methods: We searched for studies on the association between CYP2C9 genotype and sulfonylurea-induced hypoglycemia among patients with T2DM, published through August 7, 2020, using PubMed, Web of Science, and EMBASE. Odds ratios (ORs) and 95% CIs were calculated. Findings: Five cohort studies and 2 case-control studies were included, and the total number of patients analyzed in this meta-analysis was 2769. The CYP2C9 variant alleles were associated with an increase in sulfonylurea-induced hypoglycemia compared with wild-type homozygote (OR = 1.24; 95% CI, 1.03-1.48). Compared with CYP2C9 wild-type homozygotes, CYP2C9*2 allele was associated with increased incidence of hypoglycemia (OR = 1.85; 95% CI, 1.18-2.89), whereas the CYP2C9*3 allele failed to show the statistical significance (OR = 1.67; 95% CI, 0.40-6.86; P = 0.48). (C) 2021 Elsevier Inc.
more